Last week PhD student Emily, Emily Alger, presented her work on incorporating Patient-reported Outcomes in early phase adaptive trial designs at the Cancer Research UK Research Dissemination Workshop 2024.

So proud to represent the The Alan Turing Institute and The ICR at Pint of Science this week, talking all about Bayesian Statistics and early phase trials! YouTube link pending ⏳ #pint24

Delighted to present my review on the current landscape of Patient-Reported Outcomes in early phase dose-finding trials at SCTorg’s Annual Meeting this week! #SCT2024 📌 doi.org/10.1016/j.ecli…

I really loved talking about bayesian dose-finding adaptive designs at UCL Statistical Science PhD seminar last week, thank you for inviting me!

It was a pleasure to present two new dose-finding trial designs at #iscb45 in Greece this week. A great way to celebrate our newly published work! 📖 doi.org/10.1016/j.esmo…

My Pint of Science talk on bayesian statistics and its role in early phase trial design is now available on YouTube! It was an honour to represent The Alan Turing Institute and The ICR at #pint24 last year. I hope it’s a useful resource for those interested. youtu.be/-471AqKp9bw?si…